QuickMIC® GN02 Gram-negative AST for Highly Resistant Pathogens
Christer Malmberg discusses the importance of reliable cefiderocol susceptibility testing and how QuickMIC® GN02 brings cefiderocol into the rapid AST workflow.
Cefiderocol Testing in High-Resistance Settings
Cefiderocol is an important treatment option for resistant Gram-negative infections, but susceptibility testing requires specific testing conditions. In reference methods, this includes the use of specialised iron-depleted media. In this interview, Christer Malmberg, Chief Scientific Officer at Gradientech,
discusses why reliable cefiderocol susceptibility testing matters and how QuickMIC® GN02 enables phenotypic cefiderocol MIC results directly from positive blood cultures in 2–4 hours, without a separate iron-depleted media workflow.
